We need to do better for patients with non-ST-segment elevation acute coronary syndrome who are managed without revascularization.
Program for Advanced Coronary Disease, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina. Electronic address: ohman001@mc.duke.edu.
E Magnus
EM
Ohman
Program for Advanced Coronary Disease, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina.
Ralf E
RE
Harskamp
D000789:Angina, Unstable / Q000175:diagnosis* / Q000188:drug therapy*; D000077144:Clopidogrel; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine
acute coronary syndrome(s); clopidogrel; outcomes